vs
DOMO, INC.（DOMO）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
DOMO, INC.的季度营收约是RHYTHM PHARMACEUTICALS, INC.的1.4倍（$79.4M vs $57.3M），DOMO, INC.净利率更高（-13.1% vs -83.0%，领先69.9%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（36.9% vs -0.5%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（48.5% vs -0.5%）
Domo股份有限公司是总部设在美国犹他州美国福克的美国云软件企业，主营人工智能、商业智能与数据可视化业务，属于SaaS（软件即服务）企业，核心产品可帮助企业各层级决策者在极少IT介入的情况下，实时获取业务数据，支撑决策开展。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
DOMO vs RYTM — 直观对比
营收规模更大
DOMO
是对方的1.4倍
$57.3M
营收增速更快
RYTM
高出37.3%
-0.5%
净利率更高
DOMO
高出69.9%
-83.0%
两年增速更快
RYTM
近两年复合增速
-0.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $79.4M | $57.3M |
| 净利润 | $-10.4M | $-47.5M |
| 毛利率 | 74.2% | 91.6% |
| 营业利润率 | -8.7% | -82.2% |
| 净利率 | -13.1% | -83.0% |
| 营收同比 | -0.5% | 36.9% |
| 净利润同比 | 44.6% | -9.6% |
| 每股收益（稀释后） | $-0.25 | $-0.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMORYTM
| Q4 25 | $79.4M | $57.3M | ||
| Q3 25 | $79.7M | $51.3M | ||
| Q2 25 | $80.1M | $48.5M | ||
| Q1 25 | $78.8M | $32.7M | ||
| Q4 24 | $79.8M | $41.8M | ||
| Q3 24 | $78.4M | $33.3M | ||
| Q2 24 | $80.1M | $29.1M | ||
| Q1 24 | $80.2M | $26.0M |
净利润DOMORYTM
| Q4 25 | $-10.4M | $-47.5M | ||
| Q3 25 | $-22.9M | $-52.9M | ||
| Q2 25 | $-18.1M | $-46.6M | ||
| Q1 25 | $-17.7M | $-49.5M | ||
| Q4 24 | $-18.8M | $-43.3M | ||
| Q3 24 | $-19.5M | $-43.6M | ||
| Q2 24 | $-26.0M | $-32.3M | ||
| Q1 24 | $-18.7M | $-141.4M |
毛利率DOMORYTM
| Q4 25 | 74.2% | 91.6% | ||
| Q3 25 | 74.8% | 89.3% | ||
| Q2 25 | 74.2% | 88.6% | ||
| Q1 25 | 74.4% | 88.8% | ||
| Q4 24 | 75.0% | 90.9% | ||
| Q3 24 | 74.3% | 88.5% | ||
| Q2 24 | 74.1% | 89.9% | ||
| Q1 24 | 76.3% | 89.2% |
营业利润率DOMORYTM
| Q4 25 | -8.7% | -82.2% | ||
| Q3 25 | -9.1% | -102.6% | ||
| Q2 25 | -17.9% | -93.4% | ||
| Q1 25 | -15.6% | -143.7% | ||
| Q4 24 | -13.9% | -98.6% | ||
| Q3 24 | -18.5% | -132.0% | ||
| Q2 24 | -26.8% | -139.2% | ||
| Q1 24 | -16.6% | -538.7% |
净利率DOMORYTM
| Q4 25 | -13.1% | -83.0% | ||
| Q3 25 | -28.8% | -103.1% | ||
| Q2 25 | -22.5% | -96.1% | ||
| Q1 25 | -22.4% | -151.4% | ||
| Q4 24 | -23.5% | -103.6% | ||
| Q3 24 | -24.9% | -131.2% | ||
| Q2 24 | -32.5% | -110.9% | ||
| Q1 24 | -23.3% | -544.4% |
每股收益（稀释后）DOMORYTM
| Q4 25 | $-0.25 | $-0.73 | ||
| Q3 25 | $-0.56 | $-0.82 | ||
| Q2 25 | $-0.45 | $-0.75 | ||
| Q1 25 | $-0.45 | $-0.81 | ||
| Q4 24 | $-0.48 | $-0.71 | ||
| Q3 24 | $-0.51 | $-0.73 | ||
| Q2 24 | $-0.69 | $-0.55 | ||
| Q1 24 | $-0.51 | $-2.35 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $388.9M |
| 总债务越低越好 | $124.2M | — |
| 股东权益账面价值 | $-191.9M | $139.1M |
| 总资产 | $201.6M | $480.2M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DOMORYTM
| Q4 25 | — | $388.9M | ||
| Q3 25 | — | $416.1M | ||
| Q2 25 | $47.2M | $291.0M | ||
| Q1 25 | $45.3M | $314.5M | ||
| Q4 24 | — | $320.6M | ||
| Q3 24 | — | $298.4M | ||
| Q2 24 | $61.2M | $319.1M | ||
| Q1 24 | $60.9M | $201.2M |
总债务DOMORYTM
| Q4 25 | $124.2M | — | ||
| Q3 25 | $121.9M | — | ||
| Q2 25 | $119.7M | — | ||
| Q1 25 | $117.7M | — | ||
| Q4 24 | $115.6M | — | ||
| Q3 24 | $115.2M | — | ||
| Q2 24 | $114.1M | — | ||
| Q1 24 | $113.5M | — |
股东权益DOMORYTM
| Q4 25 | $-191.9M | $139.1M | ||
| Q3 25 | $-191.5M | $148.8M | ||
| Q2 25 | $-178.7M | $-11.9M | ||
| Q1 25 | $-177.2M | $18.9M | ||
| Q4 24 | $-171.2M | $21.7M | ||
| Q3 24 | $-166.4M | $11.2M | ||
| Q2 24 | $-163.5M | $39.3M | ||
| Q1 24 | $-153.5M | $61.6M |
总资产DOMORYTM
| Q4 25 | $201.6M | $480.2M | ||
| Q3 25 | $195.7M | $506.9M | ||
| Q2 25 | $189.7M | $372.7M | ||
| Q1 25 | $214.3M | $386.7M | ||
| Q4 24 | $190.2M | $392.3M | ||
| Q3 24 | $197.8M | $363.6M | ||
| Q2 24 | $204.4M | $381.8M | ||
| Q1 24 | $225.7M | $258.7M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.4M | $-25.4M |
| 自由现金流经营现金流 - 资本支出 | $1.1M | — |
| 自由现金流率自由现金流/营收 | 1.4% | — |
| 资本支出强度资本支出/营收 | 2.9% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $9.9M | — |
8季度趋势，按日历期对齐
经营现金流DOMORYTM
| Q4 25 | $3.4M | $-25.4M | ||
| Q3 25 | $3.4M | $-26.6M | ||
| Q2 25 | $4.0M | $-23.3M | ||
| Q1 25 | $8.9M | $-40.4M | ||
| Q4 24 | $-13.7M | $-18.8M | ||
| Q3 24 | $-6.2M | $-25.2M | ||
| Q2 24 | $1.9M | $-29.1M | ||
| Q1 24 | $5.4M | $-40.7M |
自由现金流DOMORYTM
| Q4 25 | $1.1M | — | ||
| Q3 25 | $1.0M | — | ||
| Q2 25 | $1.0M | — | ||
| Q1 25 | $6.7M | — | ||
| Q4 24 | $-16.2M | — | ||
| Q3 24 | $-8.4M | — | ||
| Q2 24 | $-625.0K | — | ||
| Q1 24 | $2.9M | — |
自由现金流率DOMORYTM
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | -20.3% | — | ||
| Q3 24 | -10.7% | — | ||
| Q2 24 | -0.8% | — | ||
| Q1 24 | 3.6% | — |
资本支出强度DOMORYTM
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 3.1% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
RYTM
暂无分部数据
